CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 305 enrolled
Drug / intervention
Ketamine plus usual care +1 moredrug
Likely dose
Ketamine plus usual care 35 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04129086
NCT04129086Phase 4Completed

Ketamine for Acute Pain After Trauma: KAPT Trial

The University of Texas Health Science Center, Houston·interventional·Posted Oct 16, 2019·Updated Apr 21, 2023

In Brief

A Phase 4 clinical trial evaluating Ketamine plus usual care and Usual Care for Trauma Injury and 2 related conditions. Completed, enrolled 305 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the effectiveness of Ketamine drip along with usual care and usual care alone on trauma patients and to longitudinally quantify the pain experience of patients during hospitalization.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedOct 16, 2019
Enrollment StartJul 1, 2020
Primary CompletionMar 30, 2022
Study CompletionSep 30, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 6.7 years ago

Interventions

Ketamine plus usual caredrug

Bolus of .35 mg/kg Infusion start @ 0.15 mg/kg/hr; titrate range is 0.1 - 0.25 mg/kg/hr for 24 to 48 hours after admission and each subsequent major surgery plus multi-modal pain therapy considered as standard of care. Standard of care medications include Acetaminophen 1000 mg po q6 hours, Naproxen 500 mg po q12 hours, Gabapentin 300 mg po q8 hours and Lidocaine patch q 12 hours.

Usual Caredrug

Standard of care medications include Acetaminophen 1000 mg po q6 hours, Naproxen 500 mg po q12 hours, Gabapentin 300 mg po q8 hours and Lidocaine patch q 12 hours.